4886.T लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (2 May 2024 @ 11:45):

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan...

Stats
आज की मात्रा	46 900.00
औसत मात्रा	63 641.00
बाजार मूल्य	64.22B
EPS	¥0 ( 2024-02-04 )
अगली कमाई की तारीख	( ¥0 ) 2024-05-10
Last Dividend	¥8.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	9.97
ATR14	¥2.16 (0.10%)

मात्रा सहसंबंध

लंबा: 0.05 (neutral)

छोटा: -0.12 (neutral)

Signal:(39.06) Neutral

ASKA Pharmaceutical सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

ASKA Pharmaceutical सहसंबंध - मुद्रा/वस्त्र

-0.70
( moderate negative )

-0.34
( neutral )

-0.54
( weak negative )

-0.83
( strong negative )

-0.27
( neutral )

-0.58
( weak negative )

ASKA Pharmaceutical वित्तीय

Annual	2022
राजस्व:	¥60.46B
सकल लाभ:	¥28.59B (47.28 %)
EPS:	¥150.08

FY	2022
राजस्व:	¥60.46B
सकल लाभ:	¥28.59B (47.28 %)
EPS:	¥150.08

FY	2022
राजस्व:	¥56.61B
सकल लाभ:	¥26.35B (46.55 %)
EPS:	¥151.22

Financial Reports:

No articles found.

ASKA Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥8.00 (N/A)	¥0 (N/A)	¥8.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

ASKA Pharmaceutical Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.89 - Decrease likely (22.11%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥7.00	2021-09-29
Last Dividend	¥8.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	¥31.00	--
Avg. Dividend % Per Year	0.00%	--
Score	3.32	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	3.89
Div. Directional Score	7.56	--

Next Divdend (Est)
(2024-07-03)

¥0 Estimate 0.00 %

Dividend Stability

0.09 Very Bad

Dividend Score

3.32

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8125.T	Ex Dividend Knight	2024-02-28	Annually	0.00%
7463.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
6678.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
6023.T	Ex Dividend Knight	2024-03-28	Annually	0.00%
4716.T	Ex Dividend Junior	2023-05-30	Annually	0.00%
3946.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3168.T	Ex Dividend Junior	2023-08-30	Semi-Annually	0.00%
2150.T	Ex Dividend Knight	2023-12-29	Annually	0.00%
9663.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
8624.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.105	1.500	7.90	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0687	1.200	7.71	9.25	[0 - 0.3]
returnOnEquityTTM	0.113	1.500	9.85	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.88	0.800	0.604	0.483	[1 - 3]
quickRatioTTM	1.797	0.800	4.14	3.31	[0.8 - 2.5]
cashRatioTTM	0.811	1.500	6.61	9.91	[0.2 - 2]
debtRatioTTM	0.107	-1.500	8.22	-10.00	[0 - 0.6]
interestCoverageTTM	130.07	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	204.81	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	204.81	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.167	-1.500	9.33	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.481	1.000	5.31	5.31	[0.2 - 0.8]
operatingProfitMarginTTM	0.0902	1.000	-0.197	-0.197	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.574	1.000	7.92	7.92	[0.2 - 2]
assetTurnoverTTM	0.654	0.800	8.97	7.18	[0.5 - 2]
Total Score				11.22

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	9.86	1.000	9.10	0	[1 - 100]
returnOnEquityTTM	0.113	2.50	9.91	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	204.81	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	1.764	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	204.81	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-13.08	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0935	1.000	-0.161	0	[0.1 - 0.5]
Total Score				3.89

ASKA Pharmaceutical

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.